Six Gladstone Scientists Named Among World’s Most Highly Cited Researchers
Honorees rank among the top 1 percent of researchers globally, reflecting Gladstone’s broad scientific influence.

Several options for licensing Gladstone IP are available to both new start-ups, established companies, and research institutions.
Research associate Sarp Dora Kurtoglu uses AI and gene editing in the Theodoris Lab to search for new ways to stop aortic aneurysms, driven by the patients he hopes his work will one day help.
After more than four decades of dedicated legal and governance leadership, including 22 years as a trustee, Garb will transition to emeritus status in 2027.
Gladstone scientists discover the dynamic barrier—long defined by what it excludes—imports an unexpected degree of protective proteins into the brain, revealing a new blueprint for treating Alzheimer’s disease.
In this video, Barbara Engelhardt and Deepak Srivastava explain how AI can be used to empower women to understand how their periods reflect their health.
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsDiscoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreYour gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now